Menu

Veracyte, Inc. VCYT

Full chart Compare
Set alert

Price alert · VCYT

All alert types
24.06 USD -1.86 (-7.18%)

At closeNov 11, 2026, 4:00 AM EST

24.30 +0.24 +1.00%

Pre-market · Nov 11, 4:00 AM ET

23.73 Day range 25.88
21.91 52-week range 60.91
YTD
-42.85%
1 year
-43.19%

Revenue & Expenses

Revenue by
Testing → Revenue: $493.15MRevenue → Gross Profit: $360.05MGross Profit → Net Income: $66.35MGross Profit → Selling, General & Admin: $210.95MRevenue → Cost of Revenue: $157.10MGross Profit → Research & Development: $70.81MGross Profit → Other Operating Expenses: $4.13MGross Profit → Other Expenses: $5.95MGross Profit → Income Tax: $1.85MProduct → Revenue: $14.33MBiopharmaceutical And Other → Revenue: $9.66MGross Profit$360.05MCost of Revenue$157.10MNet Income$66.35MSelling, General & Admin$210.95MResearch & Development$70.81MOther Operating Expenses$4.13MOther Expenses$5.95MIncome Tax$1.85MRevenue$517.14MTesting$493.15MProduct$14.33MBiopharmaceutical And Other$9.66M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

VCYT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
517.14M445.76M361.05M296.54M219.51M
517.14M445.76M361.05M296.54M219.51M
154.61M147.62M131.37M120.86M74.40M
362.53M298.14M229.68M175.68M145.11M
304.75M282.00M315.48M216.76M227.02M
70.81M69.29M57.30M40.60M29.84M
210.95M206.04M187.72M170.76M181.19M
57.78M16.14M-85.80M-41.08M-81.90M
1.85M1.61M-2.21M133.00K-6.09M
66.35M24.14M-74.40M-36.56M-75.56M
66.35M24.14M-74.40M-36.56M-75.56M
66.35M24.14M-74.40M-36.56M-75.56M
66.35M24.14M-74.40M-36.56M-75.56M
0.840.32-1.02-0.51-1.11
0.840.32-1.02-0.51-1.11
0.820.31-1.02-0.51-1.11
68.20M25.74M-76.61M-36.43M-81.65M
68.20M25.74M-76.61M-36.43M-81.65M
78.58M76.48M72.64M71.55M67.89M
80.57M78.16M72.64M71.55M67.89M